Cell line · CVCL_2544
KHOS-240S
Cancer cell line, Homo sapiens. Osteosarcoma. 12 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Download JSON
Cite this record
ConductScience Library. KHOS-240S. Cell lines, record CVCL_2544. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_2544
On this page
Cell line
As Cellosaurus gives it.
- Name
- KHOS-240S
- Accession
- CVCL_2544
- RRID
- RRID:CVCL_2544
- Synonyms
- KHOS240S, 240S
- Species
- Homo sapiens (Human)
- Sex
- Female
- Age at sampling
- 13Y
- Category
- Cancer cell line
- Diseases
- Osteosarcoma (NCIt C9145); Osteosarcoma (ORDO Orphanet_668)
- Derived from
- Bone, right femur (in situ)
- Parent
- KHOS/NP (CVCL_2546)
- Entry created
- 2012-04-04
- Entry updated
- 2025-04-10
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers12
1 more article gives this line's RRID in its Methods without naming the line nearby, so it is not listed.
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| The ITGB2-COPS3-SOX2 Axis and SOX2 Liquid-Liquid Phase Separation: Dual Mechanisms Governing Osteosarcoma Stemness. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| BAF complex-independent gene activation by SS18::SSX. | bioRxiv | 2026 | Its Methods give the RRID and name the line | PubMed | |
| MAT2A enhances PARN transcription via SRF to accelerate glycolysis and drive malignant progression in osteosarcoma. | Commun Biol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| DNA demethylating agents suppress preclinical models of synovial sarcoma. | J Clin Invest | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Aberrant gene activation in synovial sarcoma relies on SSX specificity and increased PRC1.1 stability. | Nat Struct Mol Biol | 2023 | Its Methods give the RRID and name the line | PubMed | |
| Prexasertib (LY2606368) reduces clonogenic survival by inducing apoptosis in primary patient-derived osteosarcoma cells and synergizes with cisplatin and talazoparib. | Int J Cancer | 2020 | Its Methods give the RRID and name the line | PubMed | |
| Characterization of Human Cancer Cell Lines by Reverse-phase Protein Arrays. | Cancer Cell | 2017 | Cellosaurus cites it | PubMed | |
| Sarcoma Cell Line Screen of Oncology Drugs and Investigational Agents Identifies Patterns Associated with Gene and microRNA Expression. | Mol Cancer Ther | 2015 | Cellosaurus cites it | PubMed | |
| A genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancers. | Cancer Res | 2010 | Cellosaurus cites it | PubMed | |
| p53 functions as a cell cycle control protein in osteosarcomas. | Mol Cell Biol | 1990 | Cellosaurus cites it | PubMed |
1 to 10 of 12
See all 12 papersRelatives2
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Parent | KHOS/NP | CVCL_2546 | Cell lines | |
| Derived from it | HOS-SL | CVCL_A9AN | Cell lines |
Cell banks4
| Cell bank | Catalog number | Status | Source |
|---|---|---|---|
| ATCC | CRL-1545 | ATCC | |
| CCTCC | GDC0254 | Cellosaurus | |
| CLS | 300433 | CLS | |
| ECACC | 86112810 | ECACC |
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_2544
GET https://conductscience.org/api/cell-lines/v1/CVCL_2544/problems